[Antithrombotic treatment and cancer].


Five to 10 % of cancers are complicated by venous thromboembolism. A score is available to classify patients according to their risk of venous thromboembolism. The long-term prophylaxis is not recommended in patients with cancer, even if it reduces the incidence of thromboembolic events, due to the high number of patients to treat to prevent one event. The… (More)
DOI: 10.1016/j.lpm.2013.06.007


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics